24
Participants
Start Date
October 25, 2024
Primary Completion Date
December 30, 2024
Study Completion Date
December 30, 2024
TeriQ Patch
"Participants will receive two single doses of either of the TeriQ patch (Strength- 28.2 µg, 56.5 µg, and 113.0 µg) approximately 1 week apart.~Route of administration- Dermal patch"
Teribone Inj.
"Participants may receive either one single dose Teribone Inj. or Forteo Inj. following TeriQ patch.~Route of administration: Sub-cutaneous Injection"
Forteo Inj.
"Participants may receive either one single dose Teribone Inj. or Forteo Inj. following TeriQ patch.~Route of administration: Sub-cutaneous Injection"
Linear Clinical Research Ltd., Nedlands
Linear Clinical Research Ltd., Joondalup
QuadMedicine
INDUSTRY